ProQR Therapeutics N.V.
PRQR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $208,991 | $145,116 | $247,552 | $452,101 |
| - Cash | $149,408 | $118,925 | $94,775 | $187,524 |
| + Debt | $17,216 | $19,734 | $21,971 | $60,372 |
| Enterprise Value | $76,799 | $45,925 | $174,748 | $324,949 |
| Revenue | $18,905 | $6,514 | $3,594 | $1,335 |
| % Growth | 190.2% | 81.2% | 169.2% | – |
| Gross Profit | $18,905 | $6,514 | $3,594 | $1,335 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$24,122 | -$24,097 | -$56,460 | -$54,948 |
| % Margin | -127.6% | -369.9% | -1,571% | -4,116% |
| Net Income | -$27,763 | -$28,119 | -$64,424 | -$60,740 |
| % Margin | -146.9% | -431.7% | -1,792.5% | -4,549.8% |
| EPS Diluted | -0.34 | -0.35 | -0.91 | -0.96 |
| % Growth | 2.9% | 61.5% | 5.2% | – |
| Operating Cash Flow | -$36,393 | $21,548 | -$68,508 | -$26,012 |
| Capital Expenditures | -$1,418 | -$1,371 | -$708 | -$484 |
| Free Cash Flow | -$37,811 | $20,177 | -$69,216 | -$26,496 |